Cor Vasa 2008, 50(10):366-367

Primární hyperaldosteronismus: epidemie, anebo jen častá příčina sekundární hypertenze?

Jiří Widimský jr.
Centrum pro hypertenzi, III. interní klinika, Všeobecná fakultní nemocnice a 1. lékařská fakulta Univerzity Karlovy, Praha, Česká republika

Published: October 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Widimský J. Primární hyperaldosteronismus: epidemie, anebo jen častá příčina sekundární hypertenze? Cor Vasa. 2008;50(10):366-367.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Litynski M. Nadcisnienie tetnicze wyvolane guzami korowo-nad-nerczowymi. Pol Tyg Lek 1953;8:204-8.
    2. Conn JW. Part I. Painting background. Part II. Primary aldosteronism, a new clinical syndrom. J Lab Clin Med 1955;43:3-17.
    3. Kaplan NM. Primary aldosteronism: an update on screening, diagnosis and treatment. Correspondence. J Hypertens 2008;26:1708-9. Go to original source... Go to PubMed...
    4. Rossi GP, Pessina AC, Heagerthy AM. Reply. Correspondence J Hypertens 2008;26:1709-10. Go to original source...
    5. Gordon RD, Stowasser M, Rutherford JC. Primary aldosteronism, are we diagnosing and operating too few patients? World J Surg 2001;25:941-7. Go to original source... Go to PubMed...
    6. Mulatero P, Dluhy RG, Giacchetti G, et al. Diagnosis of primary aldosteronism: from screening to subtype differentiation. Trends Endocrinol Metanol 2005;16: 114-9. Go to original source... Go to PubMed...
    7. Štrauch B, Zelinka T, Widimský J Jr., et al. Prevalence of primary hyperaldosteronism in middle Europe region. J Human Hypertension 2003;17:349-52. Go to original source... Go to PubMed...
    8. Rossi GP, Bernini G, Caliumi C, et al. A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients. J Am Coll Cardiol 2006;48: 2293-300. Go to original source... Go to PubMed...
    9. Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis and treatment of patients with primary aldosteronism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrin Metab 2008; sep 93/9: 3269-81. Go to original source... Go to PubMed...
    10. Widimský J jr. Sekundární hypertenze. Praha: Triton, 2003:1-151.
    11. Kaplan NM. Clinical Hypertension. Philadelphia: Lippincott Williams & Wilkins, 2006:1-550.
    12. Fritsch NM, Schiffrin EL. Aldosterone: a risk factor for vascular disease. Curr Hypertens Rep 2003;5:59-65. Go to original source... Go to PubMed...
    13. Štrauch B, Petrák O, Wichterle D, Zelinka T, Holaj R, Widimský J Jr. Increased arterial wall stiffness in primary aldosteronism in comparison with essential hypertension. Am J Hypertens 2006;19:909-14. Go to original source... Go to PubMed...
    14. Holaj R, Zelinka T, Wichterle D, Štrauch B, Petrák O, Widimský J Jr. Increased intima- media thickness of the common carotid artery in primary aldosteronism in comparison with essential hypertension. J Hypertens 2007;25:1451-7. Go to original source... Go to PubMed...
    15. Rossi GP, Bolognesi M, Rizzoni D, et al. Vascular remodelling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. Hypertension 2008;51:1366-71. Go to original source... Go to PubMed...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes